2-Chloro-2′-deoxyadenosine (CdA) is a deoxyadenosine analogue which targets enzymes involved in DNA synthesis, and hence might interfere with the resynthesis step of DNA repair. We tested this hypothesis in resting B cell chronic lymphocytic leukemia (B-CLL) lymphocytes, after firstly characterizing unscheduled DNA synthesis occurring in these cells. We observed that the spontaneous incorporation of [methyl-3 H]thymidine (dThd) into DNA of B-CLL cells was not completely inhibitable by hydroxyurea (HU) which blocks DNA replication. In addition, in the presence of HU, dThd incorporation could be upregulated by UVC radiation or DNA alkylation, without reentry of the cells into S phase. CdA was found to inhibit both spontaneous and upregulated DNA synthesis in B-CLL cells. Phosphorylation of CdA was essential to exert this effect. We finally observed a strong synergistic cytotoxicity between UV light and CdA, which was correlated with activation of caspase-3 and high molecular weight DNA fragmentation, two markers of apoptosis. Taken together, these observations indicate that in B-CLL cells CdA inhibits unscheduled DNA synthesis which represents the polymerizing step of a repair process responsive to DNA aggression. Inhibition of this process by CdA, together with a combined activation of the apoptotic proteolytic cascade by CdA and UV, may explain their synergistic cytotoxicity.
Introduction
B cell chronic lymphocytic leukemia (B-CLL) is an indolent disease in which malignant cells progressively accumulate owing to lengthened life span rather than accelerated proliferation. Indeed, among the most distinctive features of B-CLL are the inhibition of programmed cell death and the arrest in the G0/G1 phase of the cell cycle. 1 Even in clinically aggressive disease, only a small percentage of cells of G0/G1 can be detected. Quantification of this subset of proliferating cells has been reported to provide some prognostic information in B-CLL. [2] [3] [4] Contrary to what occurs in vivo, cultured B-CLL cells die from apoptosis in the absence of mitogens, cytokines such as IL-4, or autologous serum. 5 During their short in vitro lifespan, B-CLL cells, nevertheless, remain metabolically active. Indeed, cultured unstimulated B-CLL cells, similarly to normal B lymphocytes, are capable of incorporating radioactive precursors into DNA. [6] [7] [8] [9] [10] [11] This activity has been attributed to a low level of maintenance DNA repair. Accordingly, DNA synthesis in non-dividing normal lymphocytes can be enhanced by DNA damage. 6, 8, 12, 13 2-Chloro-2′-deoxyadenosine (CdA) is an adenosine deaminase-resistant analogue of deoxyadenosine, with major anti- tumor activity in indolent lymphoid malignancies, including B-CLL. 14, 15 Intracellularly, CdA is phosphorylated by deoxycytidine kinase (dCK) into its 5′-monophosphate, which is thereafter converted into its 5′-diphosphate and eventually into 2-chloro-2′-deoxyadenosine-5′-triphosphate (CdATP), the active form of CdA. Among other effects, CdATP has been shown to interfere with DNA synthesis through inhibition of ribonucleotide reductase (RR) and DNA polymerase ␤. 16 Whether this property plays a role in the killing of resting cells by CdA, as it does in proliferating cells, remains an open question. Nevertheless, since the enzymes mentioned are also involved in DNA repair, it is conceivable that CdA may interfere with forms of DNA repair that require DNA synthesis. Accordingly, CdA has been shown to block DNA repair synthesis in Xirradiated normal lymphocytes. 7, 17, 18 The synergistic killing produced by the combination of CdA with agents evoking a DNA repair response, such as alkylators, 19 could hence be explained by interference of CdA with DNA repair. The purpose of this study was to establish whether CdA may inhibit DNA synthesis for repair in B-CLL cells.
Materials and methods

Materials
CdA (Ͼ99.9% purity) was synthesized and supplied by Prof L Ghosez (Laboratory of Organic Chemistry, Louvain-la-Neuve, Belgium). CdA stock solutions were prepared in ethanol/0.9% NaCl (1/1 by volume). 9-␤-d-arabinofuranosyl-2-fluoroadenine (F-ara-A), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and hydroxyurea (HU) were from Sigma-Aldrich (Bornem, Belgium). Before each experiment, Fara-A was diluted in PBS, heated for 10 min at 100°C, titrated, and again heated before dilution in PBS. [Methyl-
]dThd, specific activity, 84 Ci/mmol) was from Amersham International (Little Chalfont, UK). [8- 3 H]CdA (24.2 or 4.7 mCi/mmol) was purchased from Moravek Biochemicals (La Brea, CA, USA). Mafosfamide (MAF) was kindly provided by Dr J Pohl (Asta Medica, Bielefeld, Germany). MAF is a cyclohexylamine salt that, after aqueous dissolution, rapidly generates 4-hydroxycyclophosphamide (4-HC), which degrades irreversibly to phosphoramide mustards, the therapeutically active metabolites of cyclophosphamide (CP). Ficoll-Paque PLUS (density: 1.077) was from Pharmacia Biotech (Roosendaal, The Netherlands). FCS and penicillin/ streptomycin were from BioWhittaker Europe (Verviers, Belgium), RPMI 1640 from Life Technologies (Merelbeke, Belgium), culture reagents from Gibco (Eggenstein, Germany), and Soluene from Packard (Brussels, Belgium).
Isolation of lymphocytes and cell culture
Freshly obtained peripheral blood of patients was fractionated by Ficoll-Paque sedimentation. All patients fulfilled the NCI criteria for the diagnosis of B-CLL, which was further confirmed by immunophenotyping. Patients studied were free of anticancer treatment (including corticosteroids) for at least 3 months, and had lymphocytes у30 000 × 10 9 /l. Mononuclear cells were washed and resuspended in RPMI 1640 supplemented with 10% FCS and 1% penicillin (10 000 U/ml)-streptomycin (10 mg/ml). Cells were counted, diluted to the indicated concentration in RPMI, and incubated at 37°C in 5% CO 2 in air.
Drug exposure and UVC radiation
In all samples, drugs were present throughout the incubation period. In some experiments, cells were transferred to 60-mm dishes and irradiated with a UVGL-25 lamp (UVP, Cambridge, UK) delivering its bulk at 254 nm. Radiation intensity was measured by a UVX-25 UV meter (UVP).
Assessment of DNA synthesis
Radioactivity incorporated into DNA was measured using the Millipore Multiscreen Assay System (Millipore, Brussels, Belgium) which includes disposable 96-well plates with a hydrophilic polyvinylidenefluoride microporous membrane (pore size 0.22 ) sealed to its bottom and a vacuum manifold. After incubation with [ 3 H]dThd (5 Ci/ml) for the indicated time, 9 × 10 5 cells were collected and dispersed in the wells of the filtration plate in triplicate. Cell-free medium containing [ 3 H]dThd was also loaded on the plates in triplicate in order to measure background binding on the filters of non-DNA bound [ 3 H]dThd. Wells were washed three times with 200 l cold PBS, and kept for 10 min with 200 l cold 8% TCA. Wells were further washed three times with 8% TCA, four times with H 2 O, and four times with 70% ethanol. After drying, filters were removed using the Multiscreen punch system (Millipore), transferred to vials and mixed with scintillation fluid. The radioactivity in DNA was measured using a liquid scintillation counter (Kontron, Basel, Switzerland). For practical reasons, when indicated, DNA synthesis was measured by the incorporation of [ 3 H]dThd into acid-insoluble cellular fractions, as explained below for the assessment of CdA incorporated into DNA. This method is adequate for experiments which last all day long since the isolated DNA can be analyzed later. The two methods for measurement of DNA synthesis were compared and yielded identical results after correction for background and normalization to the control.
Quantitation of H]CdA incorporation into DNA B-CLL lymphocytes were incubated at a concentration of 10 × 10 6 cells/ml with H]CdA (0.23 m) for 5 h. Three ml of the cell suspension were then washed twice in 5 ml of cold PBS, before addition of 350 l of 1 m HClO 4 to the pellet. Radioactivity incorporated into the acid-insoluble pellet was measured after washing and digestion with soluene.
Leukemia
Analysis of cytotoxicity and drug interaction
After drug exposure, 10 7 -CLL cells were washed with warm RPMI, resuspended in 600 l RPMI and seeded in triplicate in 96-well microtiter plates. Viability of cells after drug treatment was measured 72 h after washing, using the MTT assay. 20 The optical density (OD) of each well was measured at 540 nm with a Multiwell Scanning Spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). Leukemic cell survival (LCS) was calculated by the equation: (mean OD of treated well/mean OD of control wells) × 100. Interaction between CdA and UV light, ie synergism, additivity or antagonism, was defined according to the multiplicative and maximum models as previously described. 19, 20 Apoptosis assays Caspase-3 activity was determined with the Fluoro-Ace Apopain Assay (Bio-Rad), in which activity of the enzyme is monitored using the fluorogenic peptide substrate carbobenzoxyAsp-Glu-Val-Asp-7-amino-4-trifluoromethyl coumarin (Z-DEVD-AFC). AFC is released enzymatically by caspase-3 and its fluorescence was measured with a TM Fluorometer (BioRad) during the linear phase of enzyme kinetics. To quantify caspase-3 activity, a calibration curve using free AFC was first set up. Caspase-3 activity measured on crude cell lysates is expressed as units/mg of protein, with units equal to micromoles of AFC produced/min. 21 High molecular weight DNA fragmentation (HMWF) was analyzed by pulsed field gel electrophoresis as described. 22 Briefly, after drug treatment, 10 6 B-CLL cells were embedded in 0.6% agarose plugs. After a 24-h incubation in lysis buffer containing 1% sarkosyl and proteinase K, plugs were loaded into 1% agarose gels, and DNA separated with a CHEF-DRII system (Bio-Rad Laboratories, Richmond, CA, USA). Gels were stained with ethidium bromide and photographed. Photographs were scanned and analyzed using Scion Image software. Results are expressed in relative units, with the untreated control HMWF defined as 1 unit.
FACScan analysis
Cell cycle phase distribution of B-CLL cells was evaluated using the Cycle TEST PLUS DNA Reagent Kit (Becton Dickinson, Erembodegem-Aalst, Belgium), as described. 23 Cells were processed according to the manufacturer's instructions in order to isolate nuclei. After addition of propidium iodide, nuclei were run on a Facsort flow cytometer (Becton Dickinson). Results were analyzed using the Cell-Quest software.
Statistical analysis
All mean values were calculated from experiments performed on lymphocytes from at least three different patients. Statistical significance was assessed by the two-tailed Student's t-test for paired or unpaired samples, at a level of significance of P Ͻ 0.05.
Leukemia
Results
Upregulation of DNA synthesis by UV radiation and alkylating agents
UV radiation has been shown to impair DNA replication in cycling cells, whereas it increases DNA synthesis for repair in resting cells such as normal lymphocytes. 6, 24 We therefore investigated the effect of UV light on DNA synthesis in B-CLL lymphocytes, in the absence or in the presence of HU which inhibits semi-conservative DNA synthesis. We firstly observed that HU reduced basal [ 3 H]dThd incorporation (Figure 1 ), indicating background DNA replication. However, this effect was never complete, even at concentrations of HU higher than 1 mm (not shown), indicating background DNA synthesis activity resistant to HU. As also shown in Figure 1 , an enhancement in [ 3 H]dThd uptake was induced by UV radiation (10 J/m 2 ) both without or with HU, although the relative increase was smaller in the absence of HU (1.7 ± 0.6-fold, for n = 4) than in its presence (3.5 ± 0.7-fold, for n = 4). In the absence of HU, one sample showed a decreased uptake of dThd after UV, whereas it was increased in the three others. In the presence of HU, however, a systematic stimulation of dThd uptake was recorded after UV radiation. These observations show that HU, by abrogating DNA replication in our samples, allows the study of unscheduled DNA synthesis devoted for repair. For this reason, we decided to perform all our experiments evaluating DNA repair in the presence of 1 mm HU, which was added 30 min prior to [ To confirm that DNA synthesis elicited by UV radiation was not linked to DNA replication, cell cycle phase distribution of B-CLL cells was analyzed by FACScan analysis. Less than 0.15% of the unirradiated cells exhibited an S-phase DNA content after a 3-h incubation with HU. This proportion was not augmented by 10 J/m 2 UV, whereas in these conditions DNA synthesis measured by dThd incorporation was multiplied several fold. Accordingly, attempts to detect cycling B-CLL cells using 5-bromo-2′-deoxyuridine staining and flow cytometry remained unsuccessful (not shown).
We also evaluated the effect of MAF, a bifunctional alkylating agent causing DNA interstrand crosslinks (ICL), 25 on DNA synthesis in B-CLL cells. We had to extend the duration of incubation with MAF, since its effect took longer to appear and was less marked than that of UV light at the concentrations tested. Cells were thus incubated for 16 h with MAF and [ 3 H]dThd, in the presence of HU. This resulted in a dosedependent increase in DNA synthesis (Figure 3) , which became significant (P Ͻ 0.05) at 5 and 10 m.
Effect of CdA on DNA synthesis elicited by DNA damage
The influence of CdA, which produces inhibition of DNA replication, on UV-upregulated DNA synthesis was investigated in comparison with that of F-ara-A, which is known to inhibit DNA repair in normal lymphocytes. 6 B-CLL lymphocytes were preincubated with HU and CdA or F-ara-A for 2 h, exposed to UV (10 J/m 2 ), and thereafter allowed to perform DNA repair for 3 h in the presence of Figure 4 shows that CdA dose dependently decreased UV-induced DNA synthesis, in close parallel with F-ara-A. We also observed a time dependency of the effect of CdA on UV-
Figure 2
Dose-effect of UV radiation on unscheduled DNA synthesis. B-CLL lymphocytes, preincubated with 1 mm HU, were exposed to UV at the indicated doses and incubated for 3 h in the presence of [ 
Figure 3
Dose-effect of mafosfamide on unscheduled DNA synthesis. B-CLL lymphocytes, preincubated with 1 mm HU, were incubated with mafosfamide at the indicated doses and [ 
Figure 4
Effect of CdA and F-ara-A on DNA repair synthesis induced by UV radiation. B-CLL lymphocytes were preincubated for 2 h with 1 mm HU, and with CdA () or F-ara-A (᭺) at the indicated dose, exposed to UV (10 J/m 2 ) and allowed to undergo DNA synthesis for an additional 3 h in the presence of 
Effect of CdA on unscheduled DNA synthesis in unstimulated cells
We also assessed the effect of CdA on the spontaneous incorporation of [ 6 cells, for n = 7) and those from previously untreated patients (1038 ± 299 dpm/10 6 cells, for n = 4). However, the extent of inhibition of [ 3 H]dThd incorporation by CdA was less pronounced in the samples obtained from patients who had been pretreated with chlorambucil (CLB) or CP than in the samples from untreated subjects. At 1 m CdA, residual DNA synthesis (mean ± s.e.m.) in untreated patients (n = 4) was 31 ± 10%, whereas that in pretreated ones (n = 7) was 52 ± 5% (P = 0.04). This difference was even more marked (P = 0.01) at 10 m CdA, with remaining DNA synthesis corresponding to 19 ± 7% and 41 ± 3% of control for untreated and treated patients, respectively.
Metabolism of CdA in relation to inhibition of DNA synthesis
It has been shown in various models that formation of CdATP is a prerequisite for the cellular effects of CdA on DNA replication or cell survival. 16 We investigated whether CdA phosphorylation is also essential for inhibition of unscheduled DNA synthesis. Unstimulated B-CLL cells were incubated with
Figure 5
Effect of CdA on spontaneous unscheduled DNA synthesis. After a 2-h incubation with 1 mM HU, and CdA at the indicated concentrations, [ 3 H]dThd and increasing concentrations of dCyd. The inhibition of DNA synthesis by CdA was progressively reverted by dCyd: compared to control, dThd incorporation was 33 ± 6% without dCyd, and 83 ± 5% with 50 m dCyd (not shown).
We also studied whether UV radiation allowed a greater uptake of CdA nucleotides into the newly synthesized DNA. After a 2-h preincubation with 0.23 m [8- 3 H]CdA, cells were UV-irradiated or not, and incubated for a further 3 h. The incorporation of CdAMP into DNA (mean ± s.e.m. for n = 4) was not significantly different in control (25 ± 6 fmoles/10 6 cells) and in irradiated cells (30 ± 8 fmoles/10 6 cells).
Cell death after exposure to UV light and CdA
The inhibition exerted by CdA on repair synthesis following UV radiation led us to examine the interaction between UV light and CdA in terms of cytotoxicity. After a 2-h pre-incubation with or without 0.1 m CdA, cells were exposed to increasing UV radiation, incubated for a further 22 h in the presence of CdA, and assayed for survival using the MTT assay. As shown in Figure 6 , the dose-response curve to UV radiation was dramatically shifted to the left upon addition of CdA. Analysis of 15 individual comparisons showed that the LC 50 of the combination of CdA and UV was always lower than the product of the LC 50 of each condition alone, suggesting synergistic interaction according to the multiplicative model. Overall, the combination was significantly more toxic than the most active single condition (P Ͻ 0.00001). Caspase-3 is derived from a proenzyme (CPP32) induced at the onset of apoptosis. As shown in Figure 7 , activity of this enzyme was significantly enhanced by the combination of UV light and 0.1 m CdA. Fragmentation of genomic DNA into 50 kb pieces (HMWF) is an hallmark of apoptosis. 22 We observed, in conditions identical to those depicted in Figure 7 , that HMWF was consistently higher in samples treated with the combination of UV light and CdA (2.6 ± 0.4 relative units
Figure 6
Effect of CdA on UV-induced cell death in B-CLL lymphocytes. After a 2-h preincubation with (᭹) or without (᭺) 0.1 m CdA, cells were exposed to UV radiation at the indicated doses, and further incubated for 22 h. Cells were then assayed for survival using the MTT assay. Results are means ± s.e.m. of three experiments.
for n = 3, with control set at 1), than in those treated with CdA alone (1.7 ± 0.3) or UV light alone (0.8 ± 0.1). These results correlate with the activation of caspase-3, but also with the overall loss of cell survival evaluated by MTT 3 days later.
Discussion
We have previously shown that CdA potentiates the antitumor effect of CP in B-CLL cells, providing a rationale for the use of this association in patients. 19 To explain this synergism, it was proposed that CdA enhances the toxicity of CP derivatives by inhibiting DNA repair. CdA has indeed been shown to reduce unscheduled DNA synthesis in normal lymphocytes following ␥-irradiation, and to interfere with the repair of radioinduced DNA double-strand breaks in Chinese hamster V79 cells. 7, 18 However, an effect of CdA on DNA repair in leukemic lymphocytes had never been demonstrated. Here, we report that CdA inhibits DNA repair in B-CLL cells, both in basal conditions and after upregulation by DNA damaging conditions, and enhances the cytotoxicity of the latter.
In agreement with others, [8] [9] [10] [11] we observed in unstimulated B-CLL lymphocytes a clearly detectable incorporation of dThd into DNA, that was approximately 20 times higher than background at 22 h of incubation in the presence of HU. This basal DNA synthesis activity remained constant for at least 22 h, resulting in a linear increase in the incorporated amount of labelled dThd (see control values in Figure 2 (2 h), Figure 3 (16 h) and Figure 5 (22 h)) . The fact that this incorporation takes place despite HU, used to suppress semi-conservative DNA synthesis, shows that B-CLL cells retain a DNA repair capacity that includes a resynthesis step. HU, nevertheless, partially reduced basal incorporation of dThd. 8 An explanation for this is the possibility that HU inhibits growth of a fraction of cells which are in cycle. The presence of such cells is suggested by the finding that, in the absence of HU, UV light reduced DNA synthesis in certain samples, a characteristic response of dividing cells to UVC. Although it cannot be ruled out, a potential influence of HU on DNA repair is
Figure 7
Caspase-3 activity in B-CLL lymphocytes exposed to UV light ± CdA. Lymphocytes were incubated for 2 h with or without 0.1 m CdA, exposed or not to UV light at 10 J/m 2 , and assayed after 24 h for caspase-3 activity. Results are means ± s.e.m. of four experiments.
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assumed to be negligible in quiescent cells, as in CLL cells, because the pre-existing precursor pool is sufficient to allow repair synthesis without the need for further precursor production. 26 Our observation that HU itself, at concentrations up to 10 mm, is virtually non-toxic to CLL cells (not shown) may suggest that it did not affect basal DNA repair in these cells. This basal DNA repair activity could be markedly enhanced by UV radiation and alkylating agents, which both induce lesions, ie dipyrimidine photoproducts and covalent adducts, susceptible to removal by nucleotide-excision repair. 26 This stimulation, which occurred despite the addition of HU, was not linked to re-entry into the cell cycle. As in other reports, 6, 7, 12, 13 we found some correlation between the dose of UV or MAF and dThd incorporation, which could be explained by a proportionality between the amount of lesions and the extent of repair. The plateau observed at fluxes of UV greater than 10 J/m 2 , is similar to what has been reported by Sandoval et al 6 in normal lymphocytes. We did not attempt to elicit a maximum response by prolonging incubation after UV or by increasing MAF dose, for fear of excessive toxicity of these conditions that would compromise the analysis of DNA synthesis. Our observation of stimulatable DNA repair synthesis in B-CLL cells accords with the report in the same cells of a rapid removal of specific DNA lesions induced by alkylators or ␥-irradiation, ie DNA strand breaks or ICL. [27] [28] [29] [30] [31] [32] Our studies demonstrate that the DNA repair stimulated by UV or by MAF can be inhibited by CdA. The capacity to limit elicited DNA repair has also been shown for other nucleoside analogs, such as F-ara-A, the effect of which is also depicted in Figure 4 . 6, 10, [32] [33] [34] [35] [36] In addition, the spontaneous DNA repair synthesis occurring in B-CLL cells was also found to be reduced by CdA. This effect was not the reflection of loss of cell viability induced by prolonged incubation with CdA. Indeed, MTT performed at 24 h (at the time of measurement of [ 3 H]dThd uptake) yielded similar values in untreated cells and in those incubated with CdA at concentrations where most of the inhibition of spontaneous DNA repair is observed (not shown). This indicates that at 24 h the cells remain metabolically competent, and thus analyzable, although they might be committed to die by apoptosis later. The basal rate of DNA repair is, as shown by the control conditions in Figures 1 and  5 , an active process. Although the basis for this observation remains unknown, authors have suggested that enhanced expression of DNA repair enzymes might occur as a consequence of contact with DNA damaging drugs. 11 In our studies, this activity was highly variable between patients but did not correlate with disease stage. However, we recorded that the percentage of inhibition of this DNA repair was less pronounced in cells from patients pretreated with alkylating agents than in those from untreated patients. Although in agreement with the assumption that DNA repair may be altered in cells previously exposed to alkylators, it is not known whether it is simply linked to reduced accumulation of CdATP, or to actual resistance of the DNA repair processes. Activation of components of the repair machinery, including nucleotide analog-excising 3′-5′ exonuclease, and accelerated removal of various products of DNA damage, have been observed in resistant B-CLL cells. 27, [37] [38] [39] [40] The resistant phenotype of these cells could also be linked to coordinated regulation between proteins modulating repair and anti-apoptotic proteins. 41 The inhibition by CdA of the actively ongoing basal DNA repair may result in the accumulation of unrepaired lesions and explain why this drug elicits, in certain conditions, a typical DNA damage response. [42] [43] [44] The clinical relevance of our findings is suggested by the fact that sizable inhibition Leukemia of DNA repair is already seen at 0.05 m CdA ( Figure 5 ), a concentration achieved in vivo after bolus infusion of CdA.
The mechanisms of inhibition of DNA repair synthesis by CdA are not entirely understood. Phosphorylation of CdA by dCK is a prerequisite, since inhibition is strongly reduced in the presence of an excess of dCyd which competes with CdA for phosphorylation. After phosphorylation, the various mechanisms by which CdA could limit DNA repair include chaintermination after incorporation into DNA, direct inhibitory effects of CdATP on polymerases, imbalance in deoxynucleoside triphosphate pools, loss in ATP, lowering of NAD pools, inhibition of RNA synthesis and transcription-coupled repair, interference with DNA incision/ligation or topoisomerase functions. 16, 17, [45] [46] [47] [48] [49] We did not observe an UV-elicited increased uptake of CdA into repairing DNA. This suggests that CdA, to exert its inhibition on DNA synthesis, does not need to be incorporated into DNA. This may represent an important difference to F-ara-A, since the incorporation of the latter into DNA, followed by chain-termination, has been related with inhibition of repair after DNA damage in normal lymphocytes. 6, 32 The lack of complete inhibition of repair by CdA, especially in pretreated patients, may also imply that multiple repair processes, not all of which are inhibitable by CdA, are involved.
The inhibition of DNA repair by CdA, followed by the accumulation of DNA lesions and death by apoptosis, may explain the synergism between CdA and UV. However, other interactions leading to activation of apoptosis could be considered as suggested by the three-fold increase in caspase-3 activity by the association of CdA and UV. Indeed, the respective effects of CdA and UV could combine to synergistically initiate the two major apoptosis pathways, the Apaf-1-and the Fas/Fas-L-mediated pathways, that both converge with the irreversible activation of caspase-3. [42] [43] [44] 50 Favorable interactions have been shown between various nucleoside analogs and DNA-damaging agents, leading to clinical trials. 6, 19, 51, 52 In conclusion, we demonstrate for the first time that CdA inhibits the resynthesis step of DNA repair in B-CLL cells, and that this may be the basis (entirely or partially) for the synergism between CdA and UV light or alkylating agents. This advocates the combination of CdA with agents provoking DNA damage, a strategy that could help to circumvent resistance due to enhanced DNA repair. The association of CdA and UV light may be of therapeutic interest since UVA can be delivered to patients during extracorporeal photophoresis. Finally, we show that B-CLL cells are a good model to study DNA repair and DNA repair inhibitors.
